Stewart Fisher - 03 Aug 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Scientific Officer
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
03 Aug 2021
Net transactions value
-$767,812
Form type
4
Filing time
05 Aug 2021, 19:34:09 UTC
Previous filing
02 Aug 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Sale $767,812 -17,057 -43% $45.01* 22,744 03 Aug 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.